AP NEWS

Global Infection Control in Cancer Therapy Market Analysis & Trends 2015-2017 & Industry Forecasts 2018-2027 - ResearchAndMarkets.com

November 26, 2018

DUBLIN--(BUSINESS WIRE)--Nov 26, 2018--The “Global Infection Control in Cancer Therapy Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Infection Control in Cancer Therapy Market is poised to grow strong during the forecast period 2017 to 2027

Some of the prominent trends that the market is witnessing include increasing focus on the requirement of disinfection and sterilization, improving occurrence of hospital-acquired infections (HAIS) and growing count of surgical procedures.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Report Highlights:

The report provides a detailed analysis on current and future market trends to identify the investment opportunities Market forecasts till 2027, using estimated market values as the base numbers Key market trends across the business segments, Regions and Countries Key developments and strategies observed in the market Market Dynamics such as Drivers, Restraints, Opportunities and other trends In-depth company profiles of key players and upcoming prominent players Growth prospects among the emerging nations through 2027 Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline

1.1 Research Methodology

1.2 Market Trends

1.3 Regulatory Factors

1.4 End User Analysis

1.5 Strategic Benchmarking

1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Increasing Focus on the Requirement of Disinfection and Sterilization

3.1.2 Improving Occurrence of Hospital-Acquired Infections (HAIs)

3.1.3 Growing Count of Surgical Procedures

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Infection Control in Cancer Therapy Market, By Microorganisms

4.1 Viruses

4.2 Bacteria

4.3 Protozoa

4.4 Other Microorganisms

5 Infection Control in Cancer Therapy Market, By Treatment

5.1 Stem Cell Transplant Therapy

5.2 Targeted Therapy

5.3 Traditional Surgery

5.4 Photodynamic Therapy

5.5 Chemotherapy

5.6 Immunotherapy

5.7 Radiation Therapy

5.8 Other Treatments

6 Infection Control in Cancer Therapy Market, By End User

6.1 Medical Devices Companies

6.2 Pharmaceutical Companies

6.3 Hospitals

6.4 Other End Users

7 Infection Control in Cancer Therapy Market, By Geography

7.1 North America

7.1.1 US

7.1.2 Canada

7.1.3 Mexico

7.2 Europe

7.2.1 France

7.2.2 Germany

7.2.3 Italy

7.2.4 Spain

7.2.5 UK

7.2.6 Rest of Europe

7.3 Asia Pacific

7.3.1 China

7.3.2 Japan

7.3.3 India

7.3.4 Australia

7.3.5 New Zealand

7.3.6 Rest of Asia Pacific

7.4 Middle East

7.4.1 Saudi Arabia

7.4.2 UAE

7.4.3 Rest of Middle East

7.5 Latin America

7.5.1 Argentina

7.5.2 Brazil

7.5.3 Rest of Latin America

7.6 Rest of the World (RoW)

7.6.1 South Africa

7.6.2 Others

8 Key Player Activities

8.1 Mergers & Acquisitions

8.2 Partnerships, Joint Venture’s, Collaborations and Agreements

8.3 Product Launch & Expansions

8.4 Other Activities

9 Leading Companies

Honeywell International, Inc. 3M Healthcare Company Sterigenics International, Inc. SC Johnson Getinge Group AB Sakura Global Holding Company Fortive Vernacare Ltd Halyard Health Ingersoll-Rand Cantel Medical Kimberly Clark Corporation Reckitt Benckiser

For more information about this report visit https://www.researchandmarkets.com/research/qlpgjj/global_infection?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181126005310/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs ,Infectious Disease Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/26/2018 05:08 AM/DISC: 11/26/2018 05:08 AM

http://www.businesswire.com/news/home/20181126005310/en

AP RADIO
Update hourly